About Lystra Pharma
Lystra Pharma is a company based in Chennai (India) founded in 2020. It operates as a D2C. Lystra Pharma offers products and services including Pharmaceutical Products, Nutraceutical Products, and Health Supplements. Lystra Pharma operates in a competitive market with competitors including Pfizer, AmerisourceBergen, Entero Healthcare, Target Healthcare and CHEPLAPHARM, among others.
- Headquarter Chennai, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website lystrapharma.com
- Social Facebook
- Legal Name Lystra Pharma Private Limited
- Date of Incorporation 11 Jul, 2020
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹55.6 Lakh
FY 2024 · +240% YoY
- Net Profit₹9.2 Lakh
FY 2024 · 16% margin
- EBITDA₹14.2 Lakh
FY 2024 · 26% margin
- Employee Count1
Associated legal entities of Lystra Pharma
Lystra Pharma operates through Lystra Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lystra Pharma Private Limited CIN U51909TN2020PTC136305 | Active | 11 Jul 2020 | Chennai, Tamil Nadu | ₹0.6 Cr | – | 3 | View details |
Products & Services of Lystra Pharma
Lystra Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Products, Nutraceutical Products, and Health Supplements.
Innovative drugs from compliant APIs for various health treatments
Scientifically backed items for daily health and well-being
Effective supplements ensuring safe delivery and quality results
Board of directors of Lystra Pharma Private Limited (Lystra Pharma)
Lystra Pharma Private Limited is the primary company behind Lystra Pharma. The board of Lystra Pharma Private Limited currently have 3 directors; the longest-serving is Mary Margaret Gollapalli, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mary Margaret Gollapalli DIN 08789200 | Director | 11 Jul 2020 | 6 yrs 2 mo | Lystra Pharma Private Limited |
| Manoj Kumar Gollapalli DIN 08789199 | Director | 11 Jul 2020 | 6 yrs 2 mo | Lystra Pharma Private Limited |
| Pushparani Gollapalli DIN 09372494 | Director | 01 Jan 2022 | 4 yrs 9 mo | Lystra Pharma Private Limited |
Financials of Lystra Pharma
Figures of Lystra Pharma Private Limited, the primary company behind Lystra Pharma, for FY 2024. Revenue was ₹55.6 Lakh (+240% year on year). Net profit was ₹9.2 Lakh (16% margin). EBITDA was ₹14.2 Lakh (26% margin). Revenue has grown at a compounded annual rate of +119% over three years.
- ₹55.6 LakhRevenue · FY 2024 · +240% YoY
- ₹9.2 LakhNet profit · 16% margin
- ₹14.2 LakhEBITDA · 26% margin
- ₹2 LakhPaid-up capital
- +119%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Lystra Pharma Private Limited are on its company page.
Detailed financial statements for Lystra Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Lystra Pharma
Lystra Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pfizer, AmerisourceBergen, Entero Healthcare, Target Healthcare and CHEPLAPHARM, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| target-healthcare.co.uk | 2012 | East Kilbride, United Kingdom | $26.15M | 45 | Distributor of pharmaceutical products | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| ebosgroup.com | 1922 | Docklands, Australia | – | – | Wholesaler & distributor of healthcare, medical, and pharmaceutical products | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| renee.com | 2021 | Los Angeles, United States | $8.2M | – | Diversified drugs are distributed by Renee in the United States. | |
| neuca.pl | 1990 | Torun, Poland | – | – | Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland. | |
| sandor.co.in | 1995 | Hyderabad, India | $11.53M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed competitors of Lystra Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Lystra Pharma
10 companies that operate in the same segment as Lystra Pharma (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | – | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 80.12 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lystra Pharma
Lystra Pharma was founded in 2020.
Lystra Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Lystra Pharma has 1 employees.
The primary company behind Lystra Pharma, Lystra Pharma Private Limited, reported revenue of ₹55.6 Lakh for FY 2024, up 240% year on year.
Lystra Pharma, based in Chennai, India, develops and supplies innovative pharmaceutical, nutraceutical, and health supplements made from regulatory-compliant APIs. These products are scientifically backed for effectiveness and well-being, ensuring safe delivery and quality packaging. The company focuses on health solutions through direct inquiries and commercial dissemination, serving customers with accurate compositions and efficient pre-launch surveys.
Lystra Pharma's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.
Lystra Pharma offers Pharmaceutical Products, Nutraceutical Products, and Health Supplements.
Lystra Pharma operates through Lystra Pharma Private Limited.
The legal entities of Lystra Pharma currently have 3 directors, including Pushparani Gollapalli, Mary Margaret Gollapalli, Manoj Kumar Gollapalli.